Search clinical trials for: Laparoscopic D1 Lymphadenectomy

Total 4108 results

Samsung Medical Center
Seok Jin Kim

Terminated

Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma (ZOLINZA)

Mantle Cell Lymphoma

Korea, Republic of
Manuel Ángel Gómez-Ríos

Unknown

A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Difficult Airway Management

Endotracheal Intubation

Spain
D1 Medical Technology (Shanghai) Co., Ltd, China
Fudan University

Recruiting

Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.

Metastatic Cancer | Colon Cancer | Organoids

China
Manuel Ángel Gómez-Ríos

Completed

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Difficult Airway

Endotracheal Intubation

Spain
D1 Medical Technology (Shanghai) Co., Ltd, China
Shanghai Zhongshan Hospital

Recruiting

Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer

Gastric Cancer

China
New York State Psychiatric Institute

Completed

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

Schizophrenia | Schizoaffective Disorder

United States
Larry J. Siever
New York State Psychiatric Institute

Unknown

Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder (SPD)

Schizotypal Personality Disorder | Cognitive Impairments

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Resectable Hepatocellular Carcinoma

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
William Ondo, MD
Restless Legs Syndrome Foundation

Unknown

Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist (RLS-Ecopipam)

Restless Legs Syndrome | Augmentation

United States
Molecular NeuroImaging

Completed

Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

Healthy Volunteers

United States
Cairo University

Completed

Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus

Oral Lichen Planus
Psyadon Pharma

Completed

Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease

Lesch-Nyhan Disease

United States
National Taiwan University Hospital

Unknown

Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy (THC)

Eradication Rates of the Two Regimens

Taiwan
Blueprint Medicines Corporation

Completed

A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
Zhongnan Hospital

Unknown

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Gastric Cancer

China
National Institute on Alcohol Abuse and Alcoholism...

Recruiting

Brain Dopaminergic Signaling in Opioid Use Disorders

Normal Physiology | Opioid Use Disorders

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN); Tunitas Therapeutics, Inc.

Terminated

Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy

Cat Allergy

Australia
National Cancer Institute (NCI)

Completed

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

Mantle Cell Lymphoma | Lymphoma, Mantle Cell

United States
Aldeyra Therapeutics, Inc.

Completed

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis | Seasonal Allergies

Canada
Henry Ford Health System
Octapharma USA, Inc.

Recruiting

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

Small Fiber Neuropathy | Autoimmune Small Fiber Neuropathy | Inflammatory Polyneuropathy | Immune-Mediated Neuropathy

United States
Assistance Publique - Hôpitaux de Paris

Completed

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes (DFIL2-Child)

Type 1 Diabetes

France
Tang-Du Hospital

Active, not recruiting

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Lung Cancer | Chemotherapy | Sintilimab | Anlotinib

China
DSM Nutritional Products, Inc.
Abbott Nutrition

Completed

Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and in an Acute Stressful Situation (TSST - Trier Social Stress Test): A Randomized, Double-blind, Placebo-controlled Trial) (MemLearn)

Healthy But Chronically Stressed

Germany
Shen Lin

Unknown

Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer

Elderly Patients | Esophageal Squamous Cell Cancer

China
Manchester University NHS Foundation Trust

Recruiting

Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia Individuals (CAH-MaS)

Adrenal Hyperplasia, Congenital

United Kingdom
Heidelberg University
Stanley Medical Research Institute

Completed

Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia

Schizophrenia

Germany
Ichnos Sciences SA
Glenmark Pharmaceuticals S.A.

Terminated

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Breast Cancer

United States
Sohag University

Not yet recruiting

Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

Multiple Myeloma
AstraZeneca

Terminated

A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCope-D1)

Small Cell Lung Cancer | Non-Small Cell Lung Cancer

United States, Taiwan, New Zealand, Spain
Boehringer Ingelheim

Completed

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Leukemia, Myeloid, Acute

Germany
Medical University of Vienna

Unknown

Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients

Allergic Rhinitis | Food Allergy
Orphalan

Completed

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Wilson Disease

United States, United Kingdom, Belgium, Brazil, Denmark, France, Germany, Italy, Poland
Fudan University

Recruiting

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Triple-negative Breast Cancer

China
Fundació Institut de Recerca de l'Hospital de la...

Completed

Total IgE (Immunoglobulin E) and Der p 1 (d1) Specific IgE in Induced Sputum in Patients With Allergic and Non-allergic Asthma

Asthma

Spain
Fudan University

Completed

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

Gastric Cancer

China
Fudan University

Unknown

Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

Small Cell Lung Cancer

China
National Institute of Mental Health (NIMH)

Completed

Relationship of Dopamine to Cognitive Function in Parkinson's Disease

Parkinson Disease

United States
Fudan University

Not yet recruiting

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

TNBC - Triple-Negative Breast Cancer
National Cancer Institute (NCI)

Completed

Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma

Lymphoma

United States
National Institute of Mental Health (NIMH)

Completed

Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112

Healthy

United States
Boehringer Ingelheim

Completed

Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects

Healthy

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Celecoxib Test Formulations

Healthy Volunteers

United States
Boehringer Ingelheim

Completed

Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers

Healthy
Shanghai Children's Medical Center
Shanghai Children's Hospital

Recruiting

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Hepatoblastoma

China
Transdermal Delivery Solutions Corp
Advanced Therapies Centre, The London Clinic

Not yet recruiting

A Dose Ranging Study to Examine TDS-Testosterone 5% (PARC-T-D)

Hypogonadotropism

United Kingdom
Lihir Medical Centre
London School of Hygiene and Tropical Medicine

Completed

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

Yaws | Scabies | Lymphatic Filariases | Trachoma | Strongyloidiasis

Papua New Guinea
Novartis Pharmaceuticals

Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) (SIGNATURE)

Tumors With CDK4/6 Pathway Activation

United States
Boehringer Ingelheim

Completed

Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers

Healthy
AstraZeneca

Completed

AZD8186 First Time In Patient Ascending Dose Study

Advanced Castrate-resistant Prostate Cancer CRPC | Squamous Non-Small Cell Lung Cancer sqNSCLC | Triple Negative Breast Cancer TNBC

Spain, Canada, United States, United Kingdom

Search clinical trials for: Laparoscopic D1 Lymphadenectomy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations